Check-Cap Ltd. Share Price

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Market Closed - Nasdaq 02:00:00 01/05/2024 am IST 5-day change 1st Jan Change
2.225 USD +0.23% Intraday chart for Check-Cap Ltd. -2.84% +6.97%
Sales 2021 - Sales 2022 - Capitalization 12.81M 1.07B
Net income 2021 -17M -1.42B Net income 2022 -19M -1.59B EV / Sales 2021 -
Net cash position 2021 50.43M 4.21B Net cash position 2022 40.74M 3.4B EV / Sales 2022 -
P/E ratio 2021
-3.25 x
P/E ratio 2022
-0.65 x
Employees 85
Yield 2021 *
-
Yield 2022
-
Free-Float 74.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.23%
1 week-2.84%
1 month-28.46%
3 months+5.95%
6 months-34.75%
Current year+6.97%
More quotes
1 week
2.16
Extreme 2.1618
2.30
1 month
2.12
Extreme 2.12
2.79
Current year
1.78
Extreme 1.78
3.45
1 year
1.27
Extreme 1.27
4.63
3 years
1.22
Extreme 1.22
38.18
5 years
1.22
Extreme 1.22
89.80
10 years
1.22
Extreme 1.22
1 427.98
More quotes
Managers TitleAgeSince
Founder 63 01/05/01
Chief Tech/Sci/R&D Officer - 01/21/01
Chief Tech/Sci/R&D Officer 52 01/12/01
Members of the board TitleAgeSince
Director/Board Member 71 15/15/15
Director/Board Member 64 01/15/01
Founder 63 01/05/01
More insiders
Date Price Change Volume
30/24/30 2.225 +0.23% 17,160
29/24/29 2.22 -2.84% 9,098
26/24/26 2.285 +0.66% 22,718
25/24/25 2.27 +2.25% 31,820
24/24/24 2.22 -3.06% 27,025

Delayed Quote Nasdaq, April 01, 2024 at 02:00 am IST

More quotes
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
More about the company